Third quarter 2022 results
Third quarter 2022 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
Chief Executive Officer
Jean-Baptiste de Chatillon
Chief Financial Officer
Julie Van Ongevalle
“Our exceptional results for the third quarter demonstrate that Sanofi is on the right path. We delivered remarkable sales growth and our commitment to breakthrough science is bearing fruit as we achieved key regulatory milestones for three of our priority medicines.”
Chief Executive Officer, Sanofi